The generation of monoclonal antibodies against human peroxisome proliferator-activated receptors (PPARs).

36Citations
Citations of this article
15Readers
Mendeley users who have this article in their library.

Abstract

Monoclonal antibodies (Mabs) are valuable reagents for the purification, characterization and immunolocalization of proteins.In this study, we raised Mabs against human peroxisome proliferator-activated receptors (PPARs) using baculovirus particles displaying surface glycoprotein gp64-fusion proteins as the immunizing agent.In this system, to display fusion proteins on the viral surface, the amino terminal sequences of human PPARd and PPARg2 are inserted in-frame between the signal sequence and the mature domain of the gp64 nucleotide sequence.Mabs were raised by immunization with whole virus without a purification of the target antigens.The Mabs generated by this novel method were shown to recognize not only the gp64-PPARs fusion protein, but also mature, expressed proteins by a wide variety of techniques, including immunohistochemistry, immunoblotting, and electrophoretic mobility shift assays (EMSAs).Transfection of the transfer vector containing a nucleotide sequence encoding less than 30 amino acids along with linearized baculovirus DNA allows for the production of a high affinity antibody against the corresponding mature form.This method is of potential utility in that it allows the production of valuable antibodies without the requirement of a protein purification step.

Cite

CITATION STYLE

APA

Tanaka, T., Takeno, T., Watanabe, Y., Uchiyama, Y., Murakami, T., Yamashita, H., … Kodama, T. (2002). The generation of monoclonal antibodies against human peroxisome proliferator-activated receptors (PPARs). Journal of Atherosclerosis and Thrombosis, 9(5), 233–242. https://doi.org/10.5551/jat.9.233

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free